Batu Biologics Announces FDA Development Plans for ValloVax™ Angiogenesis-Targeting Cancer Vaccine

 Batu Biologics announced today FDA development plans for its patent-pending lead product, ValloVax™, a cancer immunotherapeutic “vaccine” that specifically targets the tumor blood vessels (endothelium). The vaccine is a “therapeutic vaccine” in that it will be used to stimulate the immune system of patients that already suffer from cancer. About Mestinon (Pyridostigmine Bromide) without prescription This is in contrast to conventional vaccines which are prophylactic, meaning that they are administered to prevent onset of disease.

“Currently the strongest evidence points to Govallo’s Vaccine, termed VG-1000, as working through inhibiting production of new blood vessels in tumors. We are aggressively pursuing this hypothesis as an underlying theme in our developmental experiments.”

ValloVax™ is comprised of isolated cells from the placenta, Metaglip (Glipizide-Metformin) with no Rx which are highly characterized and treated with a proprietary set of compounds to increase the immune system’s ability to respond to the vaccine.
“The physician-immunologist Dr. Valentin Govallo used his vaccine to treat over one hundred patients, most with incurable cancers, and reportedly had over 60% of his patients survive 10 years or longer. Subsequent to the publication of these data in his book, Immunology of Pregnancy and Cancer (Nova Publishers, 1993), numerous clinics outside of the US started to offer this therapy to cancer patients, with anecdotal reports of remissions in end stage cancer patients,” said Samuel Wagner, CEO of Batu Biologics. “Given advances in the field of immunotherapy of pregnancy and cancer, many of Dr. Govallo’s hypotheses regarding similarity between pregnancy and cancer were demonstrated correct. About Diovan Hct (Valsartan, Hydrochlorothiazide) with no prescription Unfortunately, no legitimate attempt has been made to manufacture this product in a manner consistent with FDA requirement.”
The company plans to achieve the following milestones
1. July 2014: Isolation, characterization of active cells in the placental preparation responsible for induction of anticancer immunity
2. September 2014: Animal efficacy experiments completed to identify optimum vaccine formulation. Buy Activelle with no Rx
3. December 2014: Completion of animal safety studies.
4. Q1 2015: Filing of IND to FDA for treatment of non-small stage lung cancer
“There are several paths that we are engaging to accelerate development of ValloVax™ , including leveraging existing data developed both by Batu Biologics, as well as an international collaborative network that we have established,” stated Andy Kim, VP of Scientific Research of Batu Biologics. Buy Vitamins online “Currently the strongest evidence points to Govallo’s Vaccine, termed VG-1000, as working through inhibiting production of new blood vessels in tumors. We are aggressively pursuing this hypothesis as an underlying theme in our developmental experiments.”
About Batu Biologics: Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therapies in the area of immune modulation. WebMD Consult Our products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its two flagship products: Immstem™ and Vallovax™. Batu Biologics has filed two provisional patents in the field of cancer immunotherapy and plans to significantly expand its IP in 2014. Recently, Batu Biologics published in the peer reviewed literature with Dr. Francesco Marincola, President of the Society for Immunotherapy of Cancer, as well as several other internationally-renowned immunotherapists,

Baxter and JW Holdings Announce Exclusive Global Development and Commercialization Collaboration for Omega 3 Parenteral Nutrition Products

Baxter International Inc. and JW Holdings today announced that they have entered into an exclusive distribution and license agreement for parenteral nutritional products containing a novel formulation of omega 3 lipids. With this collaboration, Baxter will complement its leading global parenteral nutrition portfolio, and provide global commercial capabilities and clinical development.
Under the terms of the agreement, Baxter will have exclusive rights to co-develop and distribute the products globally, with the exception of Korea. Buy Vibramycin (Doxycycline) pills online without prescription The arrangement includes a $25 million up-front payment that will be recorded as a special pre-tax in-process research and development charge in the third quarter of 2013. Additionally, the agreement calls for payments totaling up to $10 million for the achievement of regulatory milestones, along with royalties on future product sales.
The agreement remains in effect for 10 years following the first product launch outside of Korea. The companies will share equally in the development costs and global clinical trials and registrations. JW Holdings will manufacture the products in its Dangjin, Korea facility. Buy Viagra Super Active (Sildenafil Citrate) tabs online without prescription Additionally, Baxter has specified rights to certain additional nutritional products that JW Holdings may develop or produce in the future.
“Lipids are an important part of nutrition therapy, particularly for those patients who rely on parenteral feeding for sole-source or supplemental nutrition,” said Robert M. Davis, president of Baxter’s Medical Products business. Buy Principen (Ampicillin) without prescription “Baxter’s collaboration with JW Holdings allows us to complement our existing parenteral nutrition product portfolio and provide clinicians with additional options to meet patients’ unique nutritional needs.”
“The agreement with Baxter expands our ability to help more patients benefit from parenteral nutritional products containing our novel formulation of omega 3 lipids,” said Gu Seo Park, chief operating officer of JW Holdings. Buy Vitamins online “Both companies are bringing unique technology and expertise to this collaboration, which also will create new opportunities for JW Holdings to grow and gain recognition globally.”
About Baxter
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. BioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
About JW Holdings
JW Holdings operates as a holding company of JW Pharmaceutical which is one of the leading pharmaceutical companies in Korea. JW Group, since its foundation in 1945, has been leading therapeutic medicine industry in Korea with the business motto represented by “Respect for Life” and “Pioneering Spirit.” Drugs Rx Guide : Buy drugs online JW Group is committed to providing medicine and medical supplies in the areas including I.V. solution and circulatory, digestive, and urinary system treatments. The JW Holdings plant located in Dangjin is the largest medical manufacturing complex in Korea that supplies various medical products including non-PVC I.V. solutions and is equipped with a cutting-edge automated control system while satisfying international GMP standard.
This release includes forward-looking statements concerning a development and commercialization agreement between Baxter International Inc. and JW Holdings, including expectations with regard to the financial impact of such agreement on the company and future regulatory milestone payments. All Best Rx : Buy drugs online The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; FDA Approved Rx : Online Pharmacy actions of regulatory bodies and other governmental authorities; clinical trial results; changes in laws and regulations; product quality or patient safety issues; and other risks identified in Baxter's most recent filings on Form 10-K and other SEC filings. Baxter does not undertake to update its forward-looking statements.